Cargando…

Repurposed drugs for COVID-19: threshold and proof requirements for trials

Detalles Bibliográficos
Autores principales:	Paul, Mical, Kalil, Andre C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425289/ https://www.ncbi.nlm.nih.gov/pubmed/34508887 http://dx.doi.org/10.1016/j.cmi.2021.08.024

Ejemplares similares

Plitidepsin: a Repurposed Drug for the Treatment of COVID-19
por: Martinez, Miguel Angel
Publicado: (2021)

Buying time: Drug repurposing to treat the host in COVID‐19H
por: Martin, Jennifer H., et al.
Publicado: (2020)

Repurposing biomedical informaticians for COVID-19
por: Sosa, Daniel N., et al.
Publicado: (2021)

Repurposing an HIV Drug for Zika Virus Therapy
por: Xie, Xuping, et al.
Publicado: (2019)

Potential repurposing of oncology drugs for the treatment of Alzheimer's disease
por: Araki, Wataru
Publicado: (2013)

DRUG REPURPOSING—Overcoming the translational hurdles to clinical use
por: Martin, Jennifer H., et al.
Publicado: (2019)

Repurposing COVID-19 Drive-Through Testing Centers for Mass Vaccination
por: Kim, Edward
Publicado: (2020)

Has the door closed on hydroxychloroquine for SARS-COV-2?
por: Paul, Mical
Publicado: (2021)

COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help
por: Lentini, Giovanni, et al.
Publicado: (2020)

Clinical Trials of Repurposed Antivirals for SARS-CoV-2
por: Martinez, Miguel Angel
Publicado: (2020)

Informatics-guided drug repurposing for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Kiseleva, Anna A., et al.
Publicado: (2020)

Severe sepsis: are PROWESS and PROWESS-SHOCK trials comparable? A clinical and statistical heterogeneity analysis
por: Kalil, Andre C, et al.
Publicado: (2013)

Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

Can an FDA-Approved Alzheimer’s Drug Be Repurposed for Alleviating Neuronal Symptoms of Zika Virus?
por: Sirohi, Devika, et al.
Publicado: (2017)

Towards the network-based prediction of repurposed drugs using patient-specific metabolic models
por: Pacheco, Maria Pires, et al.
Publicado: (2019)

Repurposing exercise training and pharmacological therapies to address the post-acute sequelae of COVID-19 (PASC) in diabetes mellitus
por: Jie Chee, Ying, et al.
Publicado: (2023)

Repurposing drugs for treatment of COVID-19
por: Venkatesan, Priya
Publicado: (2021)

Drug repurposing strategies for COVID-19
por: Senanayake, Suranga L
Publicado: (2020)

Drug repurposing for the treatment of COVID-19
por: Kato, Yuri, et al.
Publicado: (2022)

Perspective: repurposed drugs for COVID-19
por: Na-Bangchang, Kesara, et al.
Publicado: (2022)

Repurposing metabolic drugs for COVID-19
por: Bordon, Yvonne
Publicado: (2023)

Repurposing Belinostat for Alleviation of Atopic Dermatitis
por: Quah, Shan, et al.
Publicado: (2021)

A new screening method for ATP-independent kinase inhibitors identifies repurposed anti-cancer drugs()
por: Timaner, Michael, et al.
Publicado: (2018)

Repurposing infectious disease vaccines for intratumoral immunotherapy
por: Melero, Ignacio, et al.
Publicado: (2020)

Editorial: Drug Repurposing
por: Pantziarka, Pan, et al.
Publicado: (2019)

Editorial: Drug Repurposing for COVID-19 Therapy
por: Maldonado, Rafael, et al.
Publicado: (2021)

Network analytics for drug repurposing in COVID-19
por: Siminea, Nicoleta, et al.
Publicado: (2021)

Repurposing anticancer drugs for the management of COVID-19
por: El Bairi, Khalid, et al.
Publicado: (2020)

Repurposing Existing Drugs for the Treatment of COVID-19
por: Farne, Hugo, et al.
Publicado: (2020)

Repurposed GI Drugs in the Treatment of COVID-19
por: Aguila, Enrik John T., et al.
Publicado: (2020)

Drug repurposing approach to fight COVID-19
por: Singh, Thakur Uttam, et al.
Publicado: (2020)

Artificial intelligence in COVID-19 drug repurposing
por: Zhou, Yadi, et al.
Publicado: (2020)

Transcription-based drug repurposing for COVID-19
por: Killick, Richard, et al.
Publicado: (2020)

Combating devastating COVID-19 by drug repurposing
por: Pawar, Ashish Yashwantrao
Publicado: (2020)

Repurposing antimalarials and other drugs for COVID-19
por: Schlagenhauf, Patricia, et al.
Publicado: (2020)

Repurposing long-term ecological studies for climate change
por: Jackson, Stephen T.
Publicado: (2023)

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
Publicado: (2020)

Medication-Wide Association Study Plus (MWAS+): A Proof of Concept Study on Drug Repurposing
por: Cheng, Yan, et al.
Publicado: (2022)

Omicron variant: assessing the duration of viral shedding and its implications
por: Cevik, Muge, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9mc069austpr38snvm376eu8ek